Interviews
By Date
Gilead Sciences: Ireland - Much More than just a Portal to the EU Market
July 2008
In this interview, Fintan Walton talks to Julie O'Neill, General Manager of Gilead Sciences Ltd
A Word from the CEO of IDA, Barry O'Leary
June 2008
In this interview, Fintan Walton talks to Barry O'Leary, CEO of IDA
Biopharma in Ireland: In Pursuit of Quality by Design
June 2008
In this panel discussion, Fintan Walton talks with key executives in Ireland.
ValiRx: Bioscience Innovation
June 2008
In this interview, Fintan Walton talks with Satu Vainikka, CEO of ValiRx
Karus Therapeutics: Better Medicines from Selective HDAC Inhibitors
June 2008
In this interview, Fintan Walton talks with Simon Kerry, CEO of Karus Therapeutics
Mercury Therapeutics: Novel approaches in the treatment of Type 2 diabetes
June 2008
In this interview, Fintan Walton talks with Dr. Neal Birnberg, CEO of Mercury Therapeutics, and Stan Yakatan, Chairman of Mercury’s Board of Directors.
AM-Pharma: Developing innovative alternatives to antibiotics
June 2008
In this interview, Fintan Walton talks to Dr. Bart Wuurman, CEO of AM-Pharma.
Apposite Capital: Ready to Take the Lead in Life Science Investments
May 2008
In this interview, Fintan Walton talks to Dr. Allan Marchington, partner in Apposite Capital.
The GI Company: Specialists in GI Medicine
May 2008
In this interview, Fintan Walton talks to Nicholas Barker, President and CEO of The GI Company.
Addex Pharmaceuticals and the Pursuit of the True Innovation
May 2008
In this conversation with Dr. Vincent Mutel, co-founder and CEO of Addex Pharmaceuticals, Fintan Walton reveals how the Addex mission—to achieve true innovation—has contributed to the tremendous success of this young biotech company.
Choose Maryland: Will this US State be the Next Silicon Valley?
May 2008
In this interview Fintan Walton speaks with Lawrence Mahan, Senior Strategy Advisor for Biosciences for the state of Maryland, and Richard Zakour, Executive Director of MdBio.
Takeda Research Investment: Reaching Beyond the Land of the Rising Sun
May 2008
This insightful conversation features Graeme Martin, CEO of Takeda Research Investment (TRI)—the corporate venture arm of Takeda Pharmaceutical.
Competition Law in the Pharmaceutical Industry: a Bird & Bird View
April 2008
In this exclusive interview Fintan Walton talks to Richard Eccles, Partner at law firm Bird & Bird.
Archimedes: A Thriving Speciality Pharma
April 2008
In this new interview, Fintan Walton talks to Richard de Souza, CEO of Archimedes Pharma.
Galapagos’ Strategic Alliances Continue to Drive its Growth
April 2008
In this exclusive interview, Fintan Walton talks to Onno van de Stolpe, CEO of Galapagos.
Strategies of a Speciality Company: EUSA Pharma
April 2008
In this exclusive interview, Fintan Walton talks to Bryan Morton, Founder and CEO of EUSA Pharma.
Outlook on Britain’s Life Science Industry
April 2008
Fintan Walton talks to Richard Barker, Director General of the ABPI.
NovaQuest: Principles and Strategies
March 2008
In this exclusive interview, Fintan Walton talks to Ben Cons, Vice President of NovaQuest.
London Genetics: Bridging the Gap
March 2008
In this exclusive interview, Fintan Walton talks to Nick Lench, CEO of London Genetics.
Interview with Lise Kagenow: Inventor and Entrepreneur
March 2008
In this exclusive interview, Fintan Walton talks to Lise Kagenow, Managing Director of Novarix.
Synta Pharmaceuticals: Strategy and Pipeline
March 2008
In this exclusive interview, Fintan Walton talks to Safi Bahcall, President and CEO of Synta Pharmaceuticals.
Impact of US Presidential Elections on Biotech
February 2008
In this exclusive interview, Fintan Walton and Matt Gardner, President and CEO of BayBio, look back on 2007
Speedel’s Renin Inhibitor Success Story
February 2008
Fintan Walton talks to Alice Huxley, CEO of the Swiss biopharmaceutical company Speedel
Indiana: A Bioscience Centre of Excellence
January 2008
Interview with Stephen Patillo and David Boncosky
Successful Partnering with the US Government through Funding for Bio-Threat Research and Development
December 2007
Interview with John Clerici
Australian Biotech: A 2007 Perspective from Alison Coutts
December 2007
Interview with Alison Coutts
Novartis’ Latest Antibody Deal with MorphoSys – Exclusive TV Interview
December 2007
Interview with Simon Moroney
Australia's Johnson & Johnson Research: Working within a Global Organisation
November 2007
Interview with Dr Susan Pond
Bristol-Myers Squibb: Business Development in a Global Community
November 2007
Interview with Graham Brazier
Licensing Deals and Acquisitions: A Legal Insight
November 2007
Interview with Marc Fredj and Richard Wallis
Novel Protein Technology Opens Doors to Danish Biotech Company
July 2007
Interview with Johanna Holldack
Roche Restructuring: An Exclusive Interview with Eric de La Fortelle, F. Hoffmann-La Roche
May 2007
Interview with Eric de La Fortelle
Vector Value: An Interview with Nick Woolf, SVP Corporate Strategy, Oxford BioMedica
May 2007
An Interview with Nick Woolf, SVP Corporate Strategy, Oxford BioMedica
Pricing and Reimbursement Risk and Opportunity in Pharmaceutical Deal Making
May 2007
Interview with Nigel Borshell
The Pharmaceutical Outlook for 2007 - A US Perspective
May 2007
An interview with Tom Quinlan and Matthew Gardner
The Pharmaceutical Outlook for 2007 - An EU Perspective
April 2007
An interview with Jeremy Curnock Cook, John Wilkinson and Jim McCarthy
The Rise of NicOx: An Interview with Damian Marron, VP Corporate Development, NicOx
April 2007
Interview with Damian Marron
Celltech: The birth of the European biotechnology industry
April 2007
Interview with Gerard Fairtlough
India, an increasingly important role in the Life Science Business
April 2007
Interview with Krishnan Nandu Nadabalan and Vimal Mehta
Sareum and Structure: An Interview with Tim Mitchell, CEO, Sareum
March 2007
Interview with Tim Mitchell
Glide Pharma: The transition from drug delivery to specialty pharma
February 2007
Special Interview with Charles Potter, Glide Pharma
Roche:Synosia Deal - Birth of an Innovative Business Strategy
February 2007
Special Interview with Synosia Therapeutics
Inhaling Success: An Interview with John Patton, CSO and Co-founder of Nektar Therapeutics.
February 2007
Interview with John Patton
Meet the Experts Special: Biotech in Australia and New Zealand
January 2007
Pharmaventures Business Review Special
Dr Anna Kluczewska, Managing Director, AION Diagnostics
December 2006
Australia Biotech Special 2006 - December 2006
Brigitte Smith, Partner, GBS Venture Partners
December 2006
Australia Biotech Special 2006 - December 2006
Meet the Experts: Australian Biotech 2006 Special
December 2006
Australia Biotech Special 2006 - December 2006
Dr Alice Huxley, CEO & President, Speedel
December 2006
Special Interview with Alice Huxley, Speedel
Rob Hockney, Director of Alliance Management, Global Discovery Alliances, AstraZeneca
November 2006
Special Interview with Rob Hockney, AstraZeneca
Stephen Farr, President & COO, and Jonathan Rigby, VP Business Development, Zogenix.
November 2006
Special Edition of PharmaVentures Business Review
Alliance Management: An Exclusive Interview with Roche
November 2006
An interview with Eric de La Fortelle
Peter Cook, CEO and Managing Director, Biota
November 2006
Special Edition of PharmaVentures Business Review
Richard de Souza, Chief Executive Officer, Archimedes Pharma
October 2006
Interview with Richard de Souza, Archimedes Pharma
Dr Mark Ashton, Executive Vice President Business Development, Evotec
October 2006
Interview with Dr Mark Ashton, Evotec
Dr H Ming Pang (Head of International Business - Simcere Pharmaceuticals, Inc., Director - Eastway Consultants Ltd HK)
October 2006
Interview with Dr H Ming Pang, Simcere Pharmaceuticals
An Interview with Fintan Walton
September 2006
Special Edition of PharmaVentures Business Review - September 2006
25 Years Young: An Interview with Bruce Carter, President and CEO of ZymoGenetics.
July 2006
Interview with Bruce Carter
